AGT and primary hyperoxaluria type 1: In our previous work, we developed a PH1 rat model that carries a nonsense (Agxt p.Q84X) mutation that results in a complete lack of AGT protein expression and develops robust hyperoxaluria early in life, closely mirroring the aggressive disease phenotype observed in a significant subset of PH1 patients.29